Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. 1 The global COPD burden is projected to increase in coming decades because of humanity's continued exposure to COPD risk factors and the aging of the population. 2 In addition, in contrast with the decreasing mortality due to cancer and cardiovascular diseases, 3 the numbers of deaths from COPD have been increasing around the world.
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It has been increasingly recognized that chronic lung disease, represented by COPD, is a risk factor for cardiovascular disease. 4 A number of population studies have shown that airflow limitation as measured by the forced expiratory volume in 1 second (FEV 1 ) or the FEV 1 /forced vital capacity ratio is a predictor of a future risk of hypertension 5 and cardiovascular risk. 6 It was reported that among US Veterans Administration inpatients, those with COPD showed higher prevalences of coronary artery disease, congestive heart failure, and atrial fibrillation than non-COPD inpatients. 7 Another group reported that COPD patients showed a higher prevalence of cerebrovascular and peripheral vascular disease than non-COPD subjects and that COPD was a risk factor for ischemic heart disease independent of traditional cardiovascular risk factors. 8 Therefore, in the treatment of patients with chronic lung disease, not only their respiratory status but also their cardiovascular risks should be considered.
Ambulatory blood pressure monitoring (ABPM) is a useful tool in the treatment of hypertension because it enables the assessment of out-of-clinic blood pressure (BP) level and BP variability. ABPM has been reported to be a better marker than conventional measurements in predicting cardiovascular target-organ damage and future cardiovascular event risk. 9 Few studies have described ambulatory BP profiles in COPD patients. At present, there are 2 reports that provided BP profiles based on ABPM in COPD patients compared with non-COPD patients. Both reported that a blunted physiological drop in BP during sleep (i.e., the nondipping pattern) was predominantly seen in COPD patients. 10, 11 However, the mechanism underlying the abnormal circadian BP rhythm observed in COPD patients has not been identified, and neither of the 2 reports mentioned above described the patients' BP levels or short-term BP variability. In addition, neither study evaluated 24-hour pulse oximetry simultaneously with the ABPM, and thus the associations between the extent of hypoxia and the ambulatory BP profiles have not yet been established.
We performed this study to clarify the association between respiratory parameters evaluated by 24-hour pulse oximetry and ABPM and the pathophysiological mechanism in patients with pneumoconiosis.
METHODS

Study participants
The subjects of this study were selected from among the participants of the Japan Morning Surge-Home Blood Pressure (J-HOP) Study. 12 The protocol of the J-HOP Study has been registered on the University Hospital Medical Information Network Clinical Trials Registry Web site under trial number UMIN000000894. Briefly, the J-HOP study is a prospective, observational, and multicenter study to evaluate predictive values of home BP for cardiovascular events in Japanese patients with any of the following cardiovascular risk factors: hypertension, impaired glucose tolerance or diabetes, dyslipidemia, smoking (including COPD), chronic renal disease, atrial fibrillation, metabolic syndrome, and sleep apnea syndrome. Exclusion criteria in the J-HOP study were a recent history of cardiovascular and cerebrovascular events (within 6 months), current hemodialysis treatment, chronic inflammatory disease, and malignancy. As a part of the J-HOP study, we recruited 19 patients with chronic hypoxia due to coal worker's pneumoconiosis. We randomly recruited 30 control subjects from J-HOP study participants matched for age and clinic BP levels but no history of chronic lung diseases. The participants were all men, ranging in age 71-86 years. The mean duration of working as a coal miner was 17.0 ± 9.1years.
Ambulatory BP monitoring
Noninvasive ambulatory BP monitoring was carried out with a validated automatic device (TM-2421 or TM-2425, A&D, Tokyo, Japan) 13 that recorded the patient's BP using an oscillometric method together with his pulse rate (PR) every 30 minutes for 24 hours. A minimum of 6 valid awake readings and 4 valid sleep readings were required for the computation of wake and sleep averages, but all subjects had many more valid readings. Twenty-four-hour BP was defined as the average of BP values recorded during a 24-hour period; nighttime BP was defined as the average of BP values from the time when the patient went to bed until the time he got out of bed, and daytime BP was defined as the average of BP values recorded during the rest of the day.
For each BP value, we estimated the SD and the coefficient of variation (CV), which was calculated as SD/mean BP × 100. The nocturnal systolic BP (SBP) fall (%) was calculated as 100 × (1-sleep SBP/awake SBP ratio). We subclassified the patients by the nocturnal SBP fall as follows: dippers if the nocturnal SBP fall was ≥10%; nondippers if it was ≥0% but <10%; and riser if it was <0%. We also subclassified the patients by the nocturnal PR dipping as follows: PR nondippers if the night/day PR ratio was ≤0.90.
Evaluation of lung function
Spirometry and blood gas were examined only in patients with pneumoconiosis. Spirometry was examined with the patients in the sitting position. Plethysmographic total lung capacity was calculated as the sum of functional residual capacity and inspiratory capacity; the residual volume was calculated as the difference between total lung capacity and slow vital capacity and is reported in liters. Vital capacity, forced vital capacity, forced expiratory volume, and FEV 1 % ((FEV 1 /forced vital capacity) × 100) were also measured with a pulmonary testing system (CHESTAC-8900; CHEST M.I., Tokyo, Japan). The status and severity of the pneumoconiosis were defined according to the Japanese Labour Health and Welfare Organization standards. 14 Blood gas was drawn from the patient's radial or femoral arteries. Pulse oximetry oxygen saturation (SpO 2 ) was measured with a validated pulse oximetry device (PULSOX Me-300; Teijin Pharma, Tokyo, Japan) 15 simultaneously with ABPM.
We performed pulse oximetry for 24 hours in patients with pneumoconiosis and only during sleep in control subjects. The oximetry device was attached to the left arm, and the sensor probe was fitted to the second or third finger and secured with tape or a finger glove to prevent detaching. The parameters analyzed were median SpO 2 , lowest SpO 2 , 3% oxygen desaturation index, and time-spent with SpO 2 <90%. Three percent oxygen desaturation index, an indicator of the severity of hypoxia, represents the number of events per hour of recording time in which the patient's blood oxygen fell by 3%. Time-spent SpO 2 <90% represents the amount of time spent with SpO 2 <90%. 16, 17 
Anthropometry and other covariables
The patients' height and weight were measured following the J-HOP protocol, 12 and their smoking and medical histories were assessed by a questionnaire administered by the authors.
In patients with pneumoconiosis, clinic BP was measured twice after a 1-2-minute interval by doctors in charge using a standard mercury sphygmomanometer based on the JSH 2009 guideline, and it was calculated as the average of 2 consecutive measurements.
In control subjects, clinic BP was measured using a validated cuff oscillometric device (HEM-5001; Omron Healthcare, Kyoto, Japan) according to the Hypertension Guidelines for the Management of Hypertension. This device automatically takes 3 measurements at 15-second intervals on each occasion, and clinic BP was calculated as the average of 3 consecutive measurements. We advised the patients to take their morning medication as usual even on the days when they were attending the clinic.
Statistical analysis
All statistical analyses were carried out with SPSS Statistics software, version 11 (SPSS, Chicago, IL). Biochemical parameters such as age, clinic SBP, diastolic BP, body mass index (BMI), estimated glomerular filtration rate, and ambulatory BP parameters are expressed as means ± SD. Because the SpO 2 values did not show a parametric distribution, they are expressed as medians. An unpaired t test was used to compare data of the patients with pneumoconiosis with those of the control subjects.
The data are expressed as means ± SD or percentages. Pearson correlation coefficients were used to calculate the correlation between the changes in parameters that showed parametric distributions and the changes in BP variability. Spearman correlation coefficients were used to calculate the parameters of hypoxia, which showed nonparametric distributions, and the changes in the measures of BP variability. We performed multiple logistic regression analysis after controlling for potential covariables such as age and BMI. Odds ratios were used to compare the risk of riser pattern between patients with pneumoconiosis and control subjects. P < 0.05 was considered significant.
RESULTS
Clinical characteristics
The clinical characteristics of 19 patients with pneumoconiosis and 30 age-matched control subjects are shown in Table 1 . BMI was significantly lower (P < 0.01) and the number (%) of current smokers tended to be lower in patients with pneumoconiosis than in control subjects. Among patients with pneumoconiosis, 7 (36.9%) were past smokers. Among patients with pneumoconiosis, 13 (68.4%) of the 19 patients were hypertensive, and 10 (76.9%) of the 13 were under antihypertensive treatments. Among control subjects, 25 (83.3%) of the 30 patients were hypertensive, and 23 (92.0%) of the 25 hypertensive patients were under antihypertensive medications.
The use of a β-blocker was significantly more frequent (P < 0.05) in control subjects than in patients with pneumoconiosis; no other significant difference was observed between the groups in the administration of oral antihypertensive drugs. Sleep length was similar between the groups. Among patients with pneumoconiosis, four (21.1%) needed to be hospitalized for pneumonia within the year before the time of study entry.
Ambulatory BP monitoring
The results of the ABPM are shown in Table 2 . The daytime SBP levels in patients with pneumoconiosis were lower (P < 0.05) than those in control subjects, but the 24-hour and nighttime SBP levels and the ambulatory Values are mean ± SD unless otherwise noted. Abbreviations: CV, coefficient of variation; BP, blood pressure; DBP, diastolic blood pressure; PR, pulse rate; SBP, systolic blood pressure.
diastolic BP levels were similar between the groups. With regard to the parameters of BP variability, the CVs in 24-hour SBP (P < 0.05) and 24-hour diastolic BP (P < 0.001) were higher in patients with pneumoconiosis than in control subjects. Although not statistically significant (P = 0.13), the odds ratio of riser pattern of BP was 3.73 in patients with pneumoconiosis. The nighttime PR value measured by ABPM was higher (P < 0.05) in patients with pneumoconiosis than in control subjects. In addition, the nondipping pattern of PR was significantly more common (P < 0.05) in patients with pneumoconiosis than in control subjects.
Evaluation of lung function
In our assessment of the status and severity of the pneumoconiosis according to the classification issued by the Japanese Labor Health and Welfare Organization, the mean severity was 3.1, which is the second most severe category among the class 1-4 categories. Two patients with pneumoconiosis were under home oxygen therapy. In patients with pneumoconiosis, the 24-hour oximetry parameters showed median SpO 2 of 94.2 ± 3.6%, lowest SpO 2 of 67.4 ± 10.0%, 3% oxygen desaturation index of 19.1 ± 9.5 times per day, and time-spent SpO 2 <90% of 13.7 ± 27.0%. Two patients under home oxygen therapy showed median 24-hour SpO 2 of 82.4% (<5 L of oxygen per minute) and 94.7% (<0.75 L of oxygen per minute).
Correlations between parameters of lung function tests and ABPM data
The relationships between the parameters of lung function tests and the daytime ambulatory SBP data in patients with pneumoconiosis are shown in Supplementary Table  S1 . Partial pressure of oxygen and partial pressure of carbon dioxide showed significant inverse correlations with BP variability in daytime SBP (SD and CV in SBP), although they were not associated with the mean daytime BP level. However, none of the other parameters of lung function tests (FEV 1 %; % vital capacity) were correlated with the mean daytime SBP level or daytime BP variability.
The relationships between the pulse oximetry parameters and ambulatory SBP parameters (daytime and nighttime) in patients with pneumoconiosis are shown in Table 3 . Regarding the relationship between daytime pulse oximetry parameters and daytime SBP, the median SpO 2 showed significant inverse correlations with the mean SBP level and the SD in SBP. Significant correlations were also seen between the lowest SpO 2 and mean SBP level, and significant inverse correlations were seen between the lowest SpO 2 and SD and CV in SBP. The time spent with SpO 2 <90% showed significant correlations with SD and CV in SBP. As for the relationships between nighttime pulse oximetry parameters and nighttime SBP, the median and lowest SpO 2 showed significant inverse correlations with SD and CV in SBP, and time spent with SpO 2 <90% showed significant correlations with SD and CV in SBP. Similar relationships were also observed between daytime pulse oximetry parameters and nighttime SBP, and between nighttime pulse oximetry parameters and daytime SBP, although such relationships were not seen in controls (Supplementary Table S2 ).
The relationships between respiratory parameters (24-hour, daytime, and nighttime) and PR from pulse oximetry in patients with pneumoconiosis are shown in Supplementary  Table S3 . Median SpO 2 and time spent with SpO 2 <90% were significantly associated with mean PR (24-hour, daytime, and nighttime; P < 0.001), and lowest nighttime SpO 2 was significantly associated with the mean nighttime PR (P < 0.05). In control subjects, only nighttime time spent with SpO2 <90% was significantly associated with nighttime mean PR (P < 0.001) (Supplementary Table S4 ).
The relationships between PR from ABPM and corresponding ambulatory BP parameters in patients with pneumoconiosis are shown in Table 4 and Figure 1 . The parameters of mean PR (24-hour, daytime, and nighttime) were significantly associated with the mean SBP levels, except for nighttime PR-SBP relationship. In contrast, the mean nighttime PR was significantly associated with the SD and CV in nighttime SBP. No such relationships were seen Table 3 . Pulse oximetry profiles and ambulatory systolic blood pressure in patients with pneumoconiosis (n = 19) Abbreviations: CV, coefficient of variation; ODI, oxygen desaturation index; SBP, systolic blood pressure; SpO 2 , pulse oximetry oxygen saturation.
*P < 0.05, **P < 0.01, ***P < 0.001.
between the other PR parameters and CV in SBP and diastolic BP or in control subjects (Supplementary Table S5 ).
DISCUSSIOn
In this pilot study, we found that in patients with pneumoconiosis, ambulatory BP variability was higher, but ambulatory BP levels tended to be lower compared with the controls. The measures of hypoxia, such as partial pressure of oxygen and time spent with SpO 2 <90%, were associated with increased BP variability. In addition, the abnormal circadian rhythm of BP riser pattern was 3.73 times higher in patients with pneumoconiosis compared with control subjects.
Our results suggest that in patients with pneumoconiosis, hypoxia could be a cause of augmented ambulatory BP variability through some specific mechanisms. There are several underlying mechanisms that bear mentioning.
There are some possible explanations why the BP levels were low in daytime in patients with pneumoconiosis. 18 First, the amount of diet consumed might be relatively small. 19 Second, BMI was lower than in control subjects (21.5 ± 2.6 vs. 24.1 ± 3.4 kg/m 2 ). It is well known that low BMI is associated with low BP levels. 20 However, BMI showed a significant positive correlation with mean 24-hour SBP only in the control subject and not in patients with pneumoconiosis (Supplementary Figure S1a,b) . Third, the lower physical activity resulting from chronic hypoxia could be associated with lower ambulatory BP levels. This is in contrast with our speculation that chronic hypoxia may result in high BP levels. We also speculate that shortness of breath due to low respiratory function may have caused a white-coat phenomenon, which resulted in lower 24-hour SBP but normal clinic SBP. Even when the clinic BP levels were equal, the ambulatory daytime BP levels in patients with pneumoconiosis were low, which seems to be a paradoxical but important finding considering its pathophysiology.
Increased BP variability has been reported to be associated with an adverse cardiovascular prognosis in hypertensive patients. [21] [22] [23] [24] There have been few reports concerning the relationship between prolonged hypoxic stress and BP variability, except in an animal study. 25 The association between decreased SpO 2 and increased BP variability was specific to patients with pneumoconiosis, but this significant association diminished when we performed multiple logistic regression analysis after controlling for potential covariables Abbreviations: CV, coefficient of variation; DBP, diastolic blood pressure; PR, pulse rate; SBP, systolic blood pressure. *P < 0.05, **P < 0.01, ***P < 0.001. Table S6 ). The same analysis after deleting 2 outliers did not change the result (n = 17; Supplementary Table S7) . It can be interpreted that the relationship between nocturnal hypoxia and large fluctuation of BP would be because of the large body size. The most plausible mechanism would be coexisting sleep apnea, which is supported by the strong correlation between BMI and SpO 2 parameters (Supplementary Figure S2) .
Low tolerance to physical activity in patients with pneumoconiosis might be another mechanism underlying the relationship between decreased SpO 2 and augmented SBP variability. Although no data of exercise tolerance were obtained in this study, we speculate that low tolerance to physical activity could be another mechanism underlying exaggerated BP variability.
Two studies reported that the nondipping pattern of BP was predominantly seen in COPD patients compared with non-COPD patients. 10, 11 The abnormal circadian rhythm of BP riser pattern was 3.73 times higher in patients with pneumoconiosis compared with control subjects. Therefore, we believe that it may have some clinical importance, even in such a small sample size. Close attention should be paid to reducing cardiovascular risks when patients with the riser pattern are identified among chronic lung disease patients.
It has been reported that resting or ambulatory PR was a predictor of all-cause mortality [26] [27] [28] and that nighttime PR was a better predictor of cerebrovascular diseases than daytime PR. 29 In addition, in patients with the nondipping pattern of PR, the risk of future CVD was shown to be higher than in patients with dipper pattern of PR, and the relationship was independent of nondipping pattern of SBP. 30 Additionally, further nocturnal hypoxia due to coexisting sleep apnea could exist in COPD patients. 31 PR during sleep is more stable and reproducible than PR during waking hours, which is subject to random fluctuations related to physical activities and occasional emotional triggers. Based on these findings, in addition to ambulatory BP parameters, the nondipping pattern of PR and ambulatory PR levels could be markers for risk stratification in hypertensive patients with chronic lung disease.
The exaggerated BP and PR variability could be explained by sympathetic nervous system activation. There are 3 explanations that show the relationship. The first explanation is the pathophysiology of the COPD or chronic lung disease. Both COPD and chronic lung disease are associated with sympathetic nervous system activation 32 due to the inhibition of pulmonary stretch receptors 33 and elevated muscle sympathetic nerve activity. 34 We speculate that pneumoconiosis could also inhibit pulmonary stretch receptors, which activate the sympathetic nervous system, resulting in exaggerated BP variability. The second explanation would be chronic hypoxia in patients with pneumoconiosis. Chronic hypoxia, especially at night, may be the cause of the increased sympathetic tone, which may be a key for the association between nighttime PR and CV in SBP. The third explanation is vascular stiffness. In a study of COPD patients with severe airflow obstruction, patients who were physically inactive were associated with endothelial dysfunction. 35 The lower baroreflex sensitivity due to the vascular stiffness 36 may result in augmented sympathetic nerve activity. Therefore, we speculate that the exaggerated BP and PR variability may be due to the sympathetic nervous system activation.
One possible mechanism of higher mean nighttime PR and higher percentage of nondipping pattern in patients with pneumoconiosis than in control subjects could be the higher percentage of ischemic heart disease and higher use of β-blockers in the control group. However, after excluding subjects with ischemic heart diseases and/or β-blocker use, these results did not essentially change in either group (Supplementary Table S8 ).
There are some limitations in this study. First, the number of patients was small. However, definite patients with pneumoconiosis are rarely seen in modern society, and these patients are important models of severe chronic lung disease. Second, our study design was cross-sectional. Third, the pulse oximetry was not performed for 24 hours in control subjects. Fourth, we did not systematically evaluate the subjects' respiratory rate, sympathetic nerve activity, or physical activity (e.g., 6-minute walk distance).
In this pilot study, exaggerated BP variability was seen in patients with pneumoconiosis, and the measures of hypoxia were associated with large fluctuations in ambulatory BP. These results indicate that even though their BP levels are not particularly high, patients with pneumoconiosis may show large fluctuations of ambulatory BP, which could be associated with a future development of cardiovascular disease. The wider use of ABPM in patients with pneumoconiosis is recommended.
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